FL

Franck Lescure

Founder of ZINCC SAS

Greater Toulouse Metropolitan Area

Overview 

Franck Lescure is currently the Founder & President of ZINCC SAS, where he oversees business strategy, corporate development, and management in the fields of innovation, technologies, and life sciences. With a background in venture capital and entrepreneurship, he has served as a board member for various companies like Flash Therapeutics and Nosopharm, and has made successful investments in companies like Pili and SeqOne Genomics.

Work Experience 

ZINCC SAS

  • Founder & President

    2023 - Current

FT

Flash Therapeutics

  • Board Member

    2016

P

Pylote

  • Board Member

    2015

N

Nosopharm

  • Board Member

    2017

F

Fab'entech

  • Board Member

    2014

PP

Pherecydes Pharma

  • Board Member

    2015 - 2023

    Board member until merger with Erytech and creation of Phaxiam Therapeutics (PHXM)

A

Aviwell

  • Board Member

    2021 - 2023

    Board member until I left Elaia Partners

P

PILI

  • Board Member

    2019 - 2023

    Board member until I left Elaia Partners

EP

Elaia Partners

  • Partner

    2018 - 2023

Honing Biosciences

  • Board Member

    2020 - 2022

    Finalized the financing seed round and transmitted the follow-up to the team after 2 years of board membership post seed round.

Education 

Investments 

Pili

Series A

Total funding: $28M

SeqOne Genomics

Seed

Total funding: $3M

Median Technologies

Series B

Total funding: $62M

Articles About Franck

Relevant Websites